Nutrition 21 (NXXI) Appoints Michael A. Zeher as CEO
Nutrition 21, Inc. (Nasdaq: NXXI) appointed Michael A. Zeher as President & Chief Executive Officer and as a member of the Board.
Mr. Zeher most recently served as President and Chief Executive Officer of Nutritional Laboratories International, Inc., recognized by Dun & Bradstreet and Entrepreneur Magazine as one of the fastest growing privately-held companies in the U.S. Prior to joining Nutritional Labs, Mr. Zeher was President and Chief Operating Officer of Pharmaceutical Formulations, Inc., a publicly-traded contract manufacturer of over 100 different types of solid-dose branded and private label over-the-counter pharmaceutical products.
Nutrition 21, Inc. develops, markets and distributes clinically substantiated nutritional supplements that target significant age- and weight-related health needs, including diabetes, cardiovascular health, obesity, mental health, cognitive function and joint health.[SM]
Related Categories
Management ChangesStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
